Three-year results of the BIO-RESORT study, presented at EuroPCR this week in Paris, put Biotronik’s ultrathin Orsiro stent ahead of two other competitors in terms of target lesion failure and revascularization.

Political unrest isn’t taking much of a toll on deals in healthcare, with executives still bullish on the sector, according to new data from Merrill Corp.

Physicians considering new technology for their practices tend to ask one or more of four questions before moving ahead: Does it actually work? Will I get paid for it? What are the liability issues? And will it work in my practice environment?

An expert consensus document endorsed by four major cardiology societies redefines cardiogenic shock based on patient descriptions, physical markers and a standardized set of vocabulary.

If the non-expansion states had seen the same increases in CRC screening, another 355,184 people would have been screened, according to authors of a recent study published in the American Journal of Preventative Medicine.

New legislation introduced in the U.S. Senate would allow radiologists to submit Medicare claims for imaging services performed by radiologist assistants (RAs) in hospitals and non-imaging services performed in the hospital or an office setting.

Results from the FDA’s latest investigation into Abiomed’s Impella RP system are in—and, with a couple of caveats, they’re positive.

Radiologists can make a significant contribution to society by acting as expert witnesses in suspected physical abuse (SBA) cases, according to a new position statement from the British Society of Pediatric Radiology (BSPR). However, certain factors do make providing such a service challenging.

A Google-affiliated company is taking on clinical trials with the pharmaceutical industry, CNBC reported. The health and life sciences business of Google’s parent company Alphabet has launched strategic alliances with Novartis, Sanofi, Otsuka and Pfizer to work in the medical studies space.

AI is becoming more accessible to researchers of any age after The Penn Medicine Institute for Biomedical Informatics launched a free, open-source automated machine learning system for anyone to use, Penn AI.